Hennion & Walsh Asset Management’s Medifast MED Stock Holding History

Hennion & Walsh Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,855	Closed	-$214K	–	842
2023 Q3	$214K	Sell	2,855 -1,707	-37%	-$151K	0.01%	735
2023 Q2	$420K	Sell	4,562 -416	-8%	-$37K	0.02%	565
2023 Q1	$516K	Buy	4,978 +394	+9%	+$43.7K	0.03%	499
2022 Q4	$529K	Buy	4,584 +2,289	+100%	+$267K	0.03%	487
2022 Q3	$249K	Sell	2,295 -311	-12%	-$44.6K	0.02%	662
2022 Q2	$470K	Sell	2,606 -101	-4%	-$18.1K	0.03%	496
2022 Q1	$462K	Buy	2,707 +159	+6%	+$30K	0.02%	530
2021 Q4	$534K	Buy	2,548 +768	+43%	+$159K	0.03%	526
2021 Q3	$343K	Buy	+1,780	New	+$438K	0.02%	606

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Hennion & Walsh Asset Management's MED Position: Q4 2023 in Review

Hennion & Walsh Asset Management sold out of Medifast (MED) in Q4 2023, closing a stake of 2,855 shares — an estimated $214K sold.

Hennion & Walsh Asset Management first reported a position in MED in Q3 2021 and held it in 9 quarters. The position peaked at $534K in Q4 2021. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

Hennion & Walsh Asset Management reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
Hennion & Walsh Asset Management sold 2,855 Medifast shares in Q4 2023, an estimated $214K.
Hennion & Walsh Asset Management first reported a position in Medifast in Q3 2021 and held it in 9 quarters.
Hennion & Walsh Asset Management's Medifast position peaked at $534K in Q4 2021.
216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.